MoonLake Immunotherapeutics
MLTX
#5866
Rank
$1.05 B
Marketcap
$14.90
Share price
-0.63%
Change (1 day)
-72.56%
Change (1 year)

Earnings for MoonLake Immunotherapeutics (MLTX)

Earnings in 2025 (TTM): -$0.22 Billion USD

According to MoonLake Immunotherapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -$0.14 Billion USD a decrease over its 2023 earnings that were of -$54.13 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MoonLake Immunotherapeutics from 2022 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$0.22 Billion60.93%
2024 -$0.14 Billion142.55%
2023 -$54.13 Million-16.81%
2022 -$65.07 Million